DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia. [electronic resource]
Producer: 20160301Description: 1614-20 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Anthracyclines -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Cohort Studies
- DNA (Cytosine-5-)-Methyltransferases -- genetics
- DNA Methyltransferase 3A
- DNA Mutational Analysis
- Female
- High-Throughput Nucleotide Sequencing
- Humans
- Induction Chemotherapy -- methods
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Nucleophosmin
- Proportional Hazards Models
- Retrospective Studies
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.